loading
Precedente Chiudi:
$48.78
Aprire:
$50.14
Volume 24 ore:
9.83M
Relative Volume:
0.33
Capitalizzazione di mercato:
$10.69B
Reddito:
$1.78B
Utile/perdita netta:
$164.40M
Rapporto P/E:
71.12
EPS:
0.69
Flusso di cassa netto:
$236.51M
1 W Prestazione:
-4.34%
1M Prestazione:
-15.87%
6M Prestazione:
+74.90%
1 anno Prestazione:
+126.09%
Intervallo 1D:
Value
$48.91
$50.19
Intervallo di 1 settimana:
Value
$46.15
$51.36
Portata 52W:
Value
$18.32
$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Name
Nome
Hims Hers Health Inc
Name
Telefono
415-851-0195
Name
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Name
Dipendente
1,637
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
HIMS's Discussions on Twitter

Confronta HIMS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
HIMS
Hims Hers Health Inc
49.10 11.03B 1.78B 164.40M 236.51M 0.69
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.09 64.68B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.19 44.25B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.21 41.19B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.52 21.74B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
420.29 18.93B 3.08B 1.24B 1.07B 25.61

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-21 Iniziato KeyBanc Capital Markets Sector Weight
2025-06-23 Downgrade Needham Buy → Hold
2025-06-04 Reiterato Needham Buy
2025-04-29 Downgrade TD Cowen Buy → Hold
2025-02-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2025-01-10 Downgrade Citigroup Neutral → Sell
2025-01-07 Iniziato BTIG Research Buy
2024-12-17 Iniziato Morgan Stanley Overweight
2024-11-14 Downgrade BofA Securities Buy → Underperform
2024-08-22 Iniziato Needham Buy
2024-08-09 Downgrade Imperial Capital Outperform → In-line
2024-05-22 Downgrade Citigroup Buy → Neutral
2024-04-16 Downgrade Jefferies Buy → Hold
2024-04-10 Iniziato Canaccord Genuity Buy
2024-02-28 Aggiornamento Imperial Capital In-line → Outperform
2024-02-26 Iniziato Leerink Partners Market Perform
2023-12-07 Iniziato Imperial Capital In-line
2023-07-28 Iniziato TD Cowen Outperform
2023-04-11 Iniziato Robert W. Baird Neutral
2023-02-09 Aggiornamento Jefferies Hold → Buy
2022-11-08 Aggiornamento BofA Securities Neutral → Buy
2022-11-08 Aggiornamento SVB Leerink Mkt Perform → Outperform
2022-10-17 Downgrade Piper Sandler Overweight → Neutral
2022-09-07 Iniziato Truist Hold
2022-07-15 Iniziato SVB Leerink Underperform
2022-04-14 Iniziato Guggenheim Buy
2022-04-01 Ripresa Credit Suisse Outperform
2022-03-10 Iniziato Deutsche Bank Hold
2021-12-02 Iniziato Jefferies Hold
2021-11-11 Aggiornamento Piper Sandler Neutral → Overweight
2021-07-06 Iniziato BofA Securities Neutral
2021-05-20 Aggiornamento Credit Suisse Neutral → Outperform
2021-04-21 Iniziato Truist Hold
2021-03-09 Iniziato Credit Suisse Neutral
2021-03-02 Aggiornamento Citigroup Neutral → Buy
2021-02-17 Iniziato Citigroup Neutral
2021-02-12 Iniziato Piper Sandler Neutral
2021-02-08 Iniziato Tigress Financial Buy
Mostra tutto

Hims Hers Health Inc Borsa (HIMS) Ultime notizie

pulisher
01:01 AM

HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - Zacks Investment Research

01:01 AM
pulisher
10:00 AM

Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo

10:00 AM
pulisher
Oct 25, 2025

Is Hims & Hers Health Still a Smart Opportunity After 124% Stock Surge in 2025? - Yahoo Finance

Oct 25, 2025
pulisher
Oct 25, 2025

Hims & Hers: Pioneering Customer-Centric Innovation with Premium Valuation - FXLeaders

Oct 25, 2025
pulisher
Oct 25, 2025

Hims & Hers: Use This Drop Before It's Too Late (NYSE:HIMS) - Seeking Alpha

Oct 25, 2025
pulisher
Oct 24, 2025

Hims & Hers Short Interest Nears All-Time High, Buy The Dip? - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Menopause Care Expansion Could Be a Game Changer for Hims & Hers Health (HIMS) - simplywall.st

Oct 24, 2025
pulisher
Oct 23, 2025

Shattering the Stigma around Menopause with Molly Sims in New York City - Hims & Hers Newsroom

Oct 23, 2025
pulisher
Oct 23, 2025

Telehealth Stock Could Rebound Off Long-Term Trendline - Schaeffer's Investment Research

Oct 23, 2025
pulisher
Oct 23, 2025

Hims & Hers: There's Opportunity In This Crash (Upgrade) - Seeking Alpha

Oct 23, 2025
pulisher
Oct 23, 2025

Hims & Hers Health, Inc. (HIMS) Stock forecasts - Yahoo

Oct 23, 2025
pulisher
Oct 23, 2025

1 Mid-Cap Stock Worth Your Attention and 2 We Avoid - The Globe and Mail

Oct 23, 2025
pulisher
Oct 23, 2025

Hims & Hers Health, Inc. (HIMS) Stock Forecasts - Yahoo

Oct 23, 2025
pulisher
Oct 22, 2025

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey

Oct 22, 2025
pulisher
Oct 22, 2025

Why Hims & Hers Stock Slipped Today - AOL.com

Oct 22, 2025
pulisher
Oct 22, 2025

Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch - Quiver Quantitative

Oct 22, 2025
pulisher
Oct 22, 2025

The Problems We’re Solving in Healthcare - Hims & Hers Newsroom

Oct 22, 2025
pulisher
Oct 22, 2025

Hims & Hers Advances AI-Powered Personalized Digital Healthcare - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Could Hims & Hers Health's (HIMS) Menopause Expansion Reveal a New Competitive Edge in Women's Care? - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026 - Fitt Insider

Oct 21, 2025
pulisher
Oct 21, 2025

Hers Health Inc. stockJuly 2025 Outlook & Fast Entry and Exit Trade Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Hims & Hers (HIMS) Faces Margin Concerns Amid Growth Plans - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

CEO Andrew Dudum Is Ditching Hims & Hers Stock. Should You? - Barchart.com

Oct 21, 2025
pulisher
Oct 21, 2025

Hims & Hers rated Sector Weight at KeyBanc on margin worries - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

HIMS Stock Declines Despite Launch of New Specialty in Women's Health - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Hims & Hers Q3 Preview: Key Metrics I Want To See For Beating 2030 Guidance (HIMS) - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

HIMS: Keybanc Initiates Coverage with 'Sector Weight' Rating | H - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Hers Health Inc. (82W) stock expanding market penetrationPortfolio Update Report & Precise Buy Zone Identification - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Investor Mood: Hers Health Inc. stock undervalued after correctionLong Setup & Long-Term Safe Investment Plans - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright - Seeking Alpha

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers CFO Okupe sells $662k in shares - Investing.com

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health CFO Sells Shares Under Trading Plan - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

HIMS CFO exercises options, sells 11,592 shares under Rule 10b5-1 - Stock Titan

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health: Roller Coaster Gift (NYSE:HIMS) - Seeking Alpha

Oct 20, 2025
pulisher
Oct 20, 2025

HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms - Zacks Investment Research

Oct 20, 2025
pulisher
Oct 20, 2025

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - sharewise.com

Oct 20, 2025
pulisher
Oct 20, 2025

Hers Health Inc.July 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

Avoiding Lag: Real-Time Signals in (HIMS) Movement - news.stocktradersdaily.com

Oct 18, 2025
pulisher
Oct 18, 2025

Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth Expectations - Yahoo Finance

Oct 18, 2025
pulisher
Oct 17, 2025

Should the New Menopause Specialty and CEO Share Sale Prompt a Closer Look at HIMS? - simplywall.st

Oct 17, 2025
pulisher
Oct 17, 2025

Why Hims & Hers stock is failing to retain menopause gains and what comes next? - CryptoRank

Oct 17, 2025
pulisher
Oct 17, 2025

Trump's Weight-Loss Drug Push May Put These ETFs On A Diet - Benzinga

Oct 17, 2025
pulisher
Oct 17, 2025

Hims & Hers CEO sells, analyst calls on Planet Fitness & Deere - Yahoo Finance

Oct 17, 2025
pulisher
Oct 17, 2025

Hims & Hers stock sinks amid launch of menopause care - The Business Journals

Oct 17, 2025
pulisher
Oct 17, 2025

Hims & Hers Stock Nosedives -- CEO Cashes Out $11 Million Stake - Yahoo Finance

Oct 17, 2025
pulisher
Oct 17, 2025

Hims & Hers Health (HIMS) Stock Tanks 15% after CEO Discloses Stock Sale - TipRanks

Oct 17, 2025
pulisher
Oct 17, 2025

Hims & Hers Health (HIMS) Stock Declines Following CEO's Major S - GuruFocus

Oct 17, 2025
pulisher
Oct 17, 2025

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom - ts2.tech

Oct 17, 2025

Hims Hers Health Inc Azioni (HIMS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.14
price up icon 0.36%
drug_manufacturers_specialty_generic RDY
$14.50
price down icon 0.55%
$10.43
price up icon 0.72%
$148.62
price up icon 3.17%
$420.26
price up icon 0.40%
Capitalizzazione:     |  Volume (24 ore):